Additional file 5: of Patterns and trends of utilization of incretin-based medicines between 2008 and 2014 in three Italian geographic areas

Additional file 1: of Decreasing trends, and geographical variation in outpatient antibiotic use: a population-based study in Central Denmark

Pia Kristensen (6627023)
SĂ¸ren Johnsen (6627026)
Reimar Thomsen (3446630)

April 2019

Table S2. shows volume of antibiotics DDD per 1000 person-years from 2006 to 2015 according to sex a...

Additional file 1: of Data collection of patients with diabetes in family medicine: a study in north-eastern Italy

Alberto Vaona (4371586)
Franco Del Zotti (4371595)
Sandro Girotto (4371592)
Claudio Marafetti (4371589)
Giulio Rigon (4371598)
Alessandro Marcon (411991)

August 2017

Map of the study area (Figure S1); review of reference guidelines on diabetes management available i...

Additional file 1: of Sex and age differences in the achievement of control targets in patients with type 2 diabetes: results from a population-based study in a South European region

K. Cambra (3402377)
A. Galbete (3402371)
L. Forga (3402356)
O. Lecea (3402362)
M. Ariz (3402365)
C. Moreno-Iribas (3402374)
F. Aizpuru (3402359)
B. IbaĂąez (3402386)

October 2016

Table S1. Type 2 diabetes prevalence by age group. Navarre (Spain), 2014 (DOCX 12 kb

Additional file 6: of Patterns and trends of utilization of incretin-based medicines between 2008 and 2014 in three Italian geographic areas

Giuseppe Roberto (3139791)
Francesco Barone-Adesi (355270)
Francesco Giorgianni (523751)
Valeria Pizzimenti (6314552)
Carmen Ferrajolo (605704)
Michele Tari (5893799)
Claudia Bartolini (6314555)
Roberto Da Cas (433997)
Marina Maggini (275336)
Stefania Spila-Alegiani (357034)
Paolo Francesconi (535541)
Gianluca TrifirĂ˛ (6314561)
Elisabetta Poluzzi (487411)
Fabio Baccetti (6314558)
Rosa Gini (451348)

February 2019

Figure S2. Age-sex standardized incidence of use of incretin-based medicines among antidiabetic drug...

Additional file 7: of Patterns and trends of utilization of incretin-based medicines between 2008 and 2014 in three Italian geographic areas

Giuseppe Roberto (3139791)
Francesco Barone-Adesi (355270)
Francesco Giorgianni (523751)
Valeria Pizzimenti (6314552)
Carmen Ferrajolo (605704)
Michele Tari (5893799)
Claudia Bartolini (6314555)
Roberto Da Cas (433997)
Marina Maggini (275336)
Stefania Spila-Alegiani (357034)
Paolo Francesconi (535541)
Gianluca TrifirĂ˛ (6314561)
Elisabetta Poluzzi (487411)
Fabio Baccetti (6314558)
Rosa Gini (451348)

February 2019

Figure S3. Prevalence of use of incretin-based medicines by age and gender. (ZIP 58 kb

Additional file 8: of Patterns and trends of utilization of incretin-based medicines between 2008 and 2014 in three Italian geographic areas

Giuseppe Roberto (3139791)
Francesco Barone-Adesi (355270)
Francesco Giorgianni (523751)
Valeria Pizzimenti (6314552)
Carmen Ferrajolo (605704)
Michele Tari (5893799)
Claudia Bartolini (6314555)
Roberto Da Cas (433997)
Marina Maggini (275336)
Stefania Spila-Alegiani (357034)
Paolo Francesconi (535541)
Gianluca TrifirĂ˛ (6314561)
Elisabetta Poluzzi (487411)
Fabio Baccetti (6314558)
Rosa Gini (451348)

February 2019

Figure S4. Incidence of use of incretin-based medicines by age and gender. (ZIP 58 kb

Additional file 9: of Patterns and trends of utilization of incretin-based medicines between 2008 and 2014 in three Italian geographic areas

Giuseppe Roberto (3139791)
Francesco Barone-Adesi (355270)
Francesco Giorgianni (523751)
Valeria Pizzimenti (6314552)
Carmen Ferrajolo (605704)
Michele Tari (5893799)
Claudia Bartolini (6314555)
Roberto Da Cas (433997)
Marina Maggini (275336)
Stefania Spila-Alegiani (357034)
Paolo Francesconi (535541)
Gianluca TrifirĂ˛ (6314561)
Elisabetta Poluzzi (487411)
Fabio Baccetti (6314558)
Rosa Gini (451348)

February 2019

Figure S5. Prevalence of use of incretin-based medicines per geographic area. (ZIP 7 kb

Additional file 10: of Patterns and trends of utilization of incretin-based medicines between 2008 and 2014 in three Italian geographic areas

Giuseppe Roberto (3139791)
Francesco Barone-Adesi (355270)
Francesco Giorgianni (523751)
Valeria Pizzimenti (6314552)
Carmen Ferrajolo (605704)
Michele Tari (5893799)
Claudia Bartolini (6314555)
Roberto Da Cas (433997)
Marina Maggini (275336)
Stefania Spila-Alegiani (357034)
Paolo Francesconi (535541)
Gianluca TrifirĂ˛ (6314561)
Elisabetta Poluzzi (487411)
Fabio Baccetti (6314558)
Rosa Gini (451348)

February 2019

Figure S6. Incidence of use of incretin-based medicines per geographic area. (PDF 7 kb

Additional file 1: of Patterns and trends of utilization of incretin-based medicines between 2008 and 2014 in three Italian geographic areas

Giuseppe Roberto (3139791)
Francesco Barone-Adesi (355270)
Francesco Giorgianni (523751)
Valeria Pizzimenti (6314552)
Carmen Ferrajolo (605704)
Michele Tari (5893799)
Claudia Bartolini (6314555)
Roberto Da Cas (433997)
Marina Maggini (275336)
Stefania Spila-Alegiani (357034)
Paolo Francesconi (535541)
Gianluca TrifirĂ˛ (6314561)
Elisabetta Poluzzi (487411)
Fabio Baccetti (6314558)
Rosa Gini (451348)

February 2019

Appendix 1. Antidiabetic drugs of interest for the study, as available in Italy during the observati...

Additional file 2: of Patterns and trends of utilization of incretin-based medicines between 2008 and 2014 in three Italian geographic areas

Giuseppe Roberto (3139791)
Francesco Barone-Adesi (355270)
Francesco Giorgianni (523751)
Valeria Pizzimenti (6314552)
Carmen Ferrajolo (605704)
Michele Tari (5893799)
Claudia Bartolini (6314555)
Roberto Da Cas (433997)
Marina Maggini (275336)
Stefania Spila-Alegiani (357034)
Paolo Francesconi (535541)
Gianluca TrifirĂ˛ (6314561)
Elisabetta Poluzzi (487411)
Fabio Baccetti (6314558)
Rosa Gini (451348)

February 2019

Appendix 2. Exposure categories for the description of antidiabetic drug treatment received by new i...

Additional file 11: of Patterns and trends of utilization of incretin-based medicines between 2008 and 2014 in three Italian geographic areas

Giuseppe Roberto (3139791)
Francesco Barone-Adesi (355270)
Francesco Giorgianni (523751)
Valeria Pizzimenti (6314552)
Carmen Ferrajolo (605704)
Michele Tari (5893799)
Claudia Bartolini (6314555)
Roberto Da Cas (433997)
Marina Maggini (275336)
Stefania Spila-Alegiani (357034)
Paolo Francesconi (535541)
Gianluca TrifirĂ˛ (6314561)
Elisabetta Poluzzi (487411)
Fabio Baccetti (6314558)
Rosa Gini (451348)

February 2019

Table S2a and S2b. Percentage of new users of GLP1 analogues by first active substance received. (DO...

Patterns and trends of utilization of incretin-based medicines between 2008 and 2014 in three Italian geographic areas

Roberto G.
Barone-Adesi F.
Giorgianni F.
Pizzimenti V.
Ferrajolo C.
Tari M.
Bartolini C.
Da Cas R.
Maggini M.
Spila-Alegiani S.
Francesconi P.
Trifiro G.
Poluzzi E.
Baccetti F.
Gini R.

January 2019

Background: The incretin-based medicines GLP1 analogues (GLP1a) and dipeptidyl peptidase-4 inhibitor...

Patterns and trends of utilization of incretin-based medicines between 2008 and 2014 in three Italian geographic areas

Giuseppe Roberto
Francesco Barone-Adesi
Francesco Giorgianni
Valeria Pizzimenti
Carmen Ferrajolo
Michele Tari
Claudia Bartolini
Roberto Da Cas
Marina Maggini
Stefania Spila-Alegiani
Paolo Francesconi
Gianluca Trifirò
Elisabetta Poluzzi
Fabio Baccetti
Rosa Gini

February 2019

Abstract Background The incretin-based medicines GLP1 analogues (GLP1a) and dipeptidyl peptidase-4 i...

Additional file 1: of Differences in drug use between men and women: an Italian cross sectional study

Daria Putignano (4411726)
Dario Bruzzese (430765)
Valentina Orlando (297589)
Denise Fiorentino (4411729)
Alessia Tettamanti (4411732)
Enrica Menditto (481190)

September 2017

Dataset prevalence. Description data: Prevalence data and Risk Ratio. (PDF 11Â kb

Patterns and trends of utilization of incretin-based medicines between 2008 and 2014 in three Italian geographic areas

Roberto G.
Barone-Adesi F.
Giorgianni F.
Pizzimenti V.
Ferrajolo C.
Tari M.
Bartolini C.
Da Cas R.
Maggini M.
Spila-Alegiani S.
Francesconi P.
Trifiro G.
Poluzzi E.
Baccetti F.
Gini R.

January 2019

Background: The incretin-based medicines GLP1 analogues (GLP1a) and dipeptidyl peptidase-4 inhibitor...

Additional file 1: of Decreasing trends, and geographical variation in outpatient antibiotic use: a population-based study in Central Denmark

Pia Kristensen (6627023)
SĂ¸ren Johnsen (6627026)
Reimar Thomsen (3446630)

April 2019

Table S2. shows volume of antibiotics DDD per 1000 person-years from 2006 to 2015 according to sex a...

Additional file 1: of Data collection of patients with diabetes in family medicine: a study in north-eastern Italy

Alberto Vaona (4371586)
Franco Del Zotti (4371595)
Sandro Girotto (4371592)
Claudio Marafetti (4371589)
Giulio Rigon (4371598)
Alessandro Marcon (411991)

August 2017

Map of the study area (Figure S1); review of reference guidelines on diabetes management available i...

Additional file 1: of Sex and age differences in the achievement of control targets in patients with type 2 diabetes: results from a population-based study in a South European region

K. Cambra (3402377)
A. Galbete (3402371)
L. Forga (3402356)
O. Lecea (3402362)
M. Ariz (3402365)
C. Moreno-Iribas (3402374)
F. Aizpuru (3402359)
B. IbaĂąez (3402386)

October 2016

Table S1. Type 2 diabetes prevalence by age group. Navarre (Spain), 2014 (DOCX 12 kb

Additional file 6: of Patterns and trends of utilization of incretin-based medicines between 2008 and 2014 in three Italian geographic areas

Giuseppe Roberto (3139791)
Francesco Barone-Adesi (355270)
Francesco Giorgianni (523751)
Valeria Pizzimenti (6314552)
Carmen Ferrajolo (605704)
Michele Tari (5893799)
Claudia Bartolini (6314555)
Roberto Da Cas (433997)
Marina Maggini (275336)
Stefania Spila-Alegiani (357034)
Paolo Francesconi (535541)
Gianluca TrifirĂ˛ (6314561)
Elisabetta Poluzzi (487411)
Fabio Baccetti (6314558)
Rosa Gini (451348)

February 2019

Figure S2. Age-sex standardized incidence of use of incretin-based medicines among antidiabetic drug...

Additional file 7: of Patterns and trends of utilization of incretin-based medicines between 2008 and 2014 in three Italian geographic areas

Giuseppe Roberto (3139791)
Francesco Barone-Adesi (355270)
Francesco Giorgianni (523751)
Valeria Pizzimenti (6314552)
Carmen Ferrajolo (605704)
Michele Tari (5893799)
Claudia Bartolini (6314555)
Roberto Da Cas (433997)
Marina Maggini (275336)
Stefania Spila-Alegiani (357034)
Paolo Francesconi (535541)
Gianluca TrifirĂ˛ (6314561)
Elisabetta Poluzzi (487411)
Fabio Baccetti (6314558)
Rosa Gini (451348)

February 2019

Figure S3. Prevalence of use of incretin-based medicines by age and gender. (ZIP 58 kb

Additional file 8: of Patterns and trends of utilization of incretin-based medicines between 2008 and 2014 in three Italian geographic areas

Giuseppe Roberto (3139791)
Francesco Barone-Adesi (355270)
Francesco Giorgianni (523751)
Valeria Pizzimenti (6314552)
Carmen Ferrajolo (605704)
Michele Tari (5893799)
Claudia Bartolini (6314555)
Roberto Da Cas (433997)
Marina Maggini (275336)
Stefania Spila-Alegiani (357034)
Paolo Francesconi (535541)
Gianluca TrifirĂ˛ (6314561)
Elisabetta Poluzzi (487411)
Fabio Baccetti (6314558)
Rosa Gini (451348)

February 2019

Figure S4. Incidence of use of incretin-based medicines by age and gender. (ZIP 58 kb

Additional file 9: of Patterns and trends of utilization of incretin-based medicines between 2008 and 2014 in three Italian geographic areas

Giuseppe Roberto (3139791)
Francesco Barone-Adesi (355270)
Francesco Giorgianni (523751)
Valeria Pizzimenti (6314552)
Carmen Ferrajolo (605704)
Michele Tari (5893799)
Claudia Bartolini (6314555)
Roberto Da Cas (433997)
Marina Maggini (275336)
Stefania Spila-Alegiani (357034)
Paolo Francesconi (535541)
Gianluca TrifirĂ˛ (6314561)
Elisabetta Poluzzi (487411)
Fabio Baccetti (6314558)
Rosa Gini (451348)

February 2019

Figure S5. Prevalence of use of incretin-based medicines per geographic area. (ZIP 7 kb

Additional file 10: of Patterns and trends of utilization of incretin-based medicines between 2008 and 2014 in three Italian geographic areas

Giuseppe Roberto (3139791)
Francesco Barone-Adesi (355270)
Francesco Giorgianni (523751)
Valeria Pizzimenti (6314552)
Carmen Ferrajolo (605704)
Michele Tari (5893799)
Claudia Bartolini (6314555)
Roberto Da Cas (433997)
Marina Maggini (275336)
Stefania Spila-Alegiani (357034)
Paolo Francesconi (535541)
Gianluca TrifirĂ˛ (6314561)
Elisabetta Poluzzi (487411)
Fabio Baccetti (6314558)
Rosa Gini (451348)

February 2019

Figure S6. Incidence of use of incretin-based medicines per geographic area. (PDF 7 kb

Additional file 1: of Patterns and trends of utilization of incretin-based medicines between 2008 and 2014 in three Italian geographic areas

Giuseppe Roberto (3139791)
Francesco Barone-Adesi (355270)
Francesco Giorgianni (523751)
Valeria Pizzimenti (6314552)
Carmen Ferrajolo (605704)
Michele Tari (5893799)
Claudia Bartolini (6314555)
Roberto Da Cas (433997)
Marina Maggini (275336)
Stefania Spila-Alegiani (357034)
Paolo Francesconi (535541)
Gianluca TrifirĂ˛ (6314561)
Elisabetta Poluzzi (487411)
Fabio Baccetti (6314558)
Rosa Gini (451348)

February 2019

Appendix 1. Antidiabetic drugs of interest for the study, as available in Italy during the observati...

Additional file 2: of Patterns and trends of utilization of incretin-based medicines between 2008 and 2014 in three Italian geographic areas

Giuseppe Roberto (3139791)
Francesco Barone-Adesi (355270)
Francesco Giorgianni (523751)
Valeria Pizzimenti (6314552)
Carmen Ferrajolo (605704)
Michele Tari (5893799)
Claudia Bartolini (6314555)
Roberto Da Cas (433997)
Marina Maggini (275336)
Stefania Spila-Alegiani (357034)
Paolo Francesconi (535541)
Gianluca TrifirĂ˛ (6314561)
Elisabetta Poluzzi (487411)
Fabio Baccetti (6314558)
Rosa Gini (451348)

February 2019

Appendix 2. Exposure categories for the description of antidiabetic drug treatment received by new i...

Additional file 11: of Patterns and trends of utilization of incretin-based medicines between 2008 and 2014 in three Italian geographic areas

Giuseppe Roberto (3139791)
Francesco Barone-Adesi (355270)
Francesco Giorgianni (523751)
Valeria Pizzimenti (6314552)
Carmen Ferrajolo (605704)
Michele Tari (5893799)
Claudia Bartolini (6314555)
Roberto Da Cas (433997)
Marina Maggini (275336)
Stefania Spila-Alegiani (357034)
Paolo Francesconi (535541)
Gianluca TrifirĂ˛ (6314561)
Elisabetta Poluzzi (487411)
Fabio Baccetti (6314558)
Rosa Gini (451348)

February 2019

Table S2a and S2b. Percentage of new users of GLP1 analogues by first active substance received. (DO...

Patterns and trends of utilization of incretin-based medicines between 2008 and 2014 in three Italian geographic areas

Roberto G.
Barone-Adesi F.
Giorgianni F.
Pizzimenti V.
Ferrajolo C.
Tari M.
Bartolini C.
Da Cas R.
Maggini M.
Spila-Alegiani S.
Francesconi P.
Trifiro G.
Poluzzi E.
Baccetti F.
Gini R.

January 2019

Background: The incretin-based medicines GLP1 analogues (GLP1a) and dipeptidyl peptidase-4 inhibitor...

Patterns and trends of utilization of incretin-based medicines between 2008 and 2014 in three Italian geographic areas

Giuseppe Roberto
Francesco Barone-Adesi
Francesco Giorgianni
Valeria Pizzimenti
Carmen Ferrajolo
Michele Tari
Claudia Bartolini
Roberto Da Cas
Marina Maggini
Stefania Spila-Alegiani
Paolo Francesconi
Gianluca Trifirò
Elisabetta Poluzzi
Fabio Baccetti
Rosa Gini

February 2019

Abstract Background The incretin-based medicines GLP1 analogues (GLP1a) and dipeptidyl peptidase-4 i...

Additional file 1: of Differences in drug use between men and women: an Italian cross sectional study

Daria Putignano (4411726)
Dario Bruzzese (430765)
Valentina Orlando (297589)
Denise Fiorentino (4411729)
Alessia Tettamanti (4411732)
Enrica Menditto (481190)

September 2017

Dataset prevalence. Description data: Prevalence data and Risk Ratio. (PDF 11Â kb

Patterns and trends of utilization of incretin-based medicines between 2008 and 2014 in three Italian geographic areas

Roberto G.
Barone-Adesi F.
Giorgianni F.
Pizzimenti V.
Ferrajolo C.
Tari M.
Bartolini C.
Da Cas R.
Maggini M.
Spila-Alegiani S.
Francesconi P.
Trifiro G.
Poluzzi E.
Baccetti F.
Gini R.

January 2019

Background: The incretin-based medicines GLP1 analogues (GLP1a) and dipeptidyl peptidase-4 inhibitor...

Additional file 1: of Decreasing trends, and geographical variation in outpatient antibiotic use: a population-based study in Central Denmark

Pia Kristensen (6627023)
SĂ¸ren Johnsen (6627026)
Reimar Thomsen (3446630)

April 2019

Table S2. shows volume of antibiotics DDD per 1000 person-years from 2006 to 2015 according to sex a...

Additional file 1: of Data collection of patients with diabetes in family medicine: a study in north-eastern Italy

Alberto Vaona (4371586)
Franco Del Zotti (4371595)
Sandro Girotto (4371592)
Claudio Marafetti (4371589)
Giulio Rigon (4371598)
Alessandro Marcon (411991)

August 2017

Map of the study area (Figure S1); review of reference guidelines on diabetes management available i...

Additional file 1: of Sex and age differences in the achievement of control targets in patients with type 2 diabetes: results from a population-based study in a South European region

K. Cambra (3402377)
A. Galbete (3402371)
L. Forga (3402356)
O. Lecea (3402362)
M. Ariz (3402365)
C. Moreno-Iribas (3402374)
F. Aizpuru (3402359)
B. IbaĂąez (3402386)

October 2016

Table S1. Type 2 diabetes prevalence by age group. Navarre (Spain), 2014 (DOCX 12 kb

Additional file 5: of Patterns and trends of utilization of incretin-based medicines between 2008 and 2014 in three Italian geographic areas

Abstract

Extracted data

Additional file 5: of Patterns and trends of utilization of incretin-based medicines between 2008 and 2014 in three Italian geographic areas

Abstract

Extracted data

Related items

Related items